Skip to Primary Navigation

Skip to main content

Novo Nordisk to cap insulin prices in Minnesota settlement

Image of the words "Novo Nordisk" on a car door.
Photo: Tim de Waele/Corbis via Getty Images

Julie DiMauro

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The settlement filed in a New Jersey federal court follows similar settlements last year with Eli Lilly and French drugmaker Sanofi.

All Minnesotans, with or without insurance, can now buy Novo Nordisk’s insulin products for $35 per month for the next five years. Minnesota Attorney General Keith Ellison announced a settlement with Denmark-based pharmaceutical company Novo Nordisk that guarantees this policy.

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk

, , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience